VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1%
Wed, 12 Jun

VENUS REMEDIES has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

VENUS REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m93269186425.1%-7.3%
Other incomeRs m3538714.4%1036.2%
TurnoverRs m93569590229.7%-3.6%
ExpensesRs m83864383529.8%-0.4%
Gross profitRs m9447-61-227.8%-164.6%
DepreciationRs m6283830.0%34.1%
InterestRs m98940-100.0%-100.0%
Profit before taxRs m-62-125-105
TaxRs m32-6-1-103.3%
Profit after taxRs m-94-119-104
Gross profit margin%10.16.9-7.0
Effective tax rate%-50.94.41.0
Net profit margin%-10.0-17.2-11.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 7.3% on a year-on-year (YoY) basis. The expenses were down by 0.4% YoY during the same period.
  • The company's operating profit declined by 164.6% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 7.0% in 4QFY19 as against 10.1% in 4QFY18.
  • Depreciation charges increased by 34.1% and finance costs declined by 100.0% YoY, respectively.
  • Other income increased by 1036.2% YoY during the quarter.
  • Net profit for the quarter declined by 11.1% YoY. Net profit margins during the quarter declined from -10.0% in 4QFY18 to -11.6% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 25.1% on a quarter-on-quarter (QoQ) basis. The expenses were up by 29.8% QoQ during the same period.
  • The company's operating profit declined by 227.8% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 7.0% in 4QFY19 as against 6.9% in 3QFY18.
  • Net profit for the quarter increased by 12.7% QoQ, while net profit margins increased from -17.1% in 3QFY18 to -11.6% in 4QFY19.

To see how VENUS REMEDIES has performed over the last eight quarters, please visit here.

VENUS REMEDIES Share Price Performance

Over the last one year, VENUS REMEDIES share price has moved up from Rs 57.1 to Rs 27.4, registering a Loss of Rs 29.7 or around 52.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,132.3 (up 0.0%). Over the last one year it has moved down from 13,755.6 to 13,132.3, a gain of 623 points (down 4.5%).

Overall, the S&P BSE SENSEX is up 12.2% over the year.

Current Valuations

At the current price of Rs 27.4, the price to book value (P/BV) ratio of VENUS REMEDIES stands at 0.1 times.

Equitymaster requests your view! Post a comment on "VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1%". Click here!

  

Related Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

VENUS REMEDIES SHARE PRICE


Feb 26, 2021 03:20 PM

TRACK VENUS REMEDIES

  • Track your investment in VENUS REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VENUS REMEDIES

VENUS REMEDIES - NEULAND LABS COMPARISON

COMPARE VENUS REMEDIES WITH

MARKET STATS